Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

178 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-12-31

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The recent swine origin influenza pandemic (2009), new emergence of swine origin H3N2v, and delayed availability of vaccine for these agents highlight the need to test and optimize public health intervention strategies to reduce transmission of influenza. We will use a new technology for biological particle collection (U.S. Provisional Patent Application No. 61/162,395, McDevitt et al., Aerosol Sci Technol 2013) to make fundamental observations on infectious respiratory droplets in a study of up to 200 naturally occurring seasonal influenza cases. We will collect respiratory droplets shed by participants while breathing normally, talking, and spontaneously coughing. We will characterize the size distribution of droplets containing infectious virus. We will use these basic data to examine the roles of large and small respiratory droplets and examine how the interaction of host factors and virus type impact the shedding of infectious respiratory droplets. Subjects will be recruited through a web based respiratory illness surveillance system, health clinics and advertisement in the campus community. Sitting in the collection booth will not create additional discomfort or risk for volunteers already suffering from influenza infection. We will recruit up to 1000 persons with symptoms of acute respiratory illness for screening with collection of nasopharyngeal swabs and questionnaire. From among those screened, we will recruit 250 to give exhaled breath samples, and ask 50 people with influenza to return for follow up exhaled breath samples on up to two subsequent days. We hypothesize that (1) fine aerosols (\<5 microns in aerodynamic diameter) will contain more viral copies than coarse aerosol particles (\>= 5 microns) (2) fine aerosols will contain culturable virus indicating that the fine aerosols are infectious, (3) aerosol shedding will correlate with virus load measured by swabs, (4) presence of active cough during sampling will be associated with increased aerosol shedding, (5) clinical symptoms and signs, including fever can be used to predict viral aerosol shedding.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluating Modes of Influenza Transmission Between Humans

NCT01150149

Influenza

WITHDRAWN NA

DMID 21-0041; Influenza CVD 59000

NCT05666245

Influenza

COMPLETED NA

Evaluating Modes of Influenza Transmission 2b Baseline SAR

NCT07342556

Influenza (Healthy Volunteers)

NOT_YET_RECRUITING NA

Evaluating Modes of Influenza Transmission

NCT01710111

Influenza, Human

COMPLETED NA

Respiratory Virus Outpatient Study (FLU 002 Plus)

NCT01056354

Influenza and Other Novel Respiratory Viruses

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a follow-on to earlier projects funded by the US Centers for Disease Control and Prevention (CDC) and the National Institute for Allergy and Infectious Diseases (NIAID) that developed the sampler and studied the impact of surgical masks on reducing viral aerosol release by persons infected with influenza virus. The funding organizations have no direct control over the study design, execution, or reporting and no access to identifiable human data. The CDC IRB has determined that the CDC is not engaged in human subjects research in this cooperative agreement.

Hypotheses:

* Fine particle aerosols will contain greater numbers of viral copies than will coarse aerosol particles.
* Clinical symptoms and signs, including fever can be used to predict viral aerosol shedding
* Fine aerosols will contain culturable virus indicating that the fine aerosols are infectious
* Aerosol shedding will correlate with virus load measured by nasopharyngeal and throat swabs
* Presence of active cough during sampling will be associated with increased aerosol shedding with a stronger correlation to be found with coarse than fine particle virus aerosols

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza Virus Infection Transmission in Humans

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Community acquired respiratory infection

Measurement of exhaled breath aerosol

Observational Study of influenza aerosol shedding -- No Intervention

Intervention Type OTHER

No intervention -- observational study only

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational Study of influenza aerosol shedding -- No Intervention

No intervention -- observational study only

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Presence of symptomatic respiratory infection or other evidence of respiratory infection:

* During the influenza season, subjects will be enrolled if they have

* influenza-like illness (symptoms of fever and either cough or sore throat) and either
* a positive point of care rapid test for influenza infection or
* objectively documented fever in the setting of a documented local influenza outbreak (presence of rapid test or PCR confirmed cases).
* Onset within the previous 48 hours
* Prior to onset of influenza season and if we have not achieved enrollment of our target population by the end of flu season, we will enroll subjects with cough, coryza (stuffy runny nose, sore throat, sneezing), and malaise (fatigue) characteristic of the 'common cold' often resulting from Human Rhinovirus, RSV, parainfluenza, and to some extent influenza virus.